Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DX-104
- Development stage
- Phase 1
- Lead developer
- Delonix Bioworks
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DX-104 is a recombinant outer membrane vesicle (OMV) vaccine candidate developed by Delonix Bioworks (Shanghai Yuguan Biotech) for the prevention of invasive meningococcal disease caused by serogroup B *Neisseria meningitidis*. The vaccine is produced using the proprietary OMV Plus® platform, which utilizes genetically engineered bacteria to produce OMVs with optimized antigen presentation and enhanced immunogenicity. This platform is designed to be highly scalable and cost-effective, aiming to provide a more accessible alternative to existing MenB vaccines. DX-104 is currently undergoing Phase I clinical evaluation to assess its safety and immunogenicity in healthy adults, with the licensed vaccine Bexsero serving as a positive control.
- Other names
- Group B Meningococcal OMV Vaccine
02
Targets
Neisseria meningitidis serogroup B outer membrane antigens
Beyond the preview
Go deeper on DX-104.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DX-104.